These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 3267451)

  • 61. Use of the hamster embryo cell transformation assay to detect metabolic activation of N-2-acetylaminofluorene by intact organ cells.
    Poiley JA; Ernst MK; Cavanaugh DM; Raineri R
    J Appl Toxicol; 1983 Dec; 3(6):326-31. PubMed ID: 6677656
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Metabolic activation of 2-acetylaminofluorene by isolated rat liver cells. Involvement of different metabolites causing DNA-repair and bacterial mutagenesis.
    Brouns RM; Bos RP; von Doorn R; Henderson PT
    Arch Toxicol; 1980 May; 45(1):53-9. PubMed ID: 6994684
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Differential regulation of mdr genes in response to 2-acetylaminofluorene treatment in cultured rat and human hepatocytes.
    Lecureur V; Guillouzo A; Fardel O
    Carcinogenesis; 1996 May; 17(5):1157-60. PubMed ID: 8640928
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Prevention by thioethers of the hepatotoxicity and covalent binding to macromolecules of N-hydroxy-2-acetylaminofluorene and its sulfate ester in rat liver in vivo and in vitro.
    van den Goorbergh JA; de Wit H; Tijdens RB; Mulder GJ; Meerman JH
    Carcinogenesis; 1987 Feb; 8(2):275-9. PubMed ID: 2433070
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Loss of sexual differentiation of metabolism of steroids and xenobiotics in nodular hepatic tissue from male and female Wistar rats treated according to the resistant hepatocyte model.
    Blanck A; Hällström IP; Eriksson LC
    Carcinogenesis; 1990 Jul; 11(7):1067-73. PubMed ID: 2372866
    [TBL] [Abstract][Full Text] [Related]  

  • 66. The effect of quercetin, a mutagenicity-enhancing agent, on the metabolism of 2-acetylaminofluorene with mammalian metabolic activation systems.
    Ogawa S; Hirayama T; Tokuda M; Hirai K; Fukui S
    Mutat Res; 1986 Sep; 162(2):179-86. PubMed ID: 3528828
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Metabolism of 2-acetylaminofluorene by two 3-methylcholanthrene-inducible forms of rat liver cytochrome P-450.
    Goldstein JA; Weaver R; Sundheimer DW
    Cancer Res; 1984 Sep; 44(9):3768-71. PubMed ID: 6744296
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Cytoskeleton modifications induced by phenobarbital, 2-acetylaminofluorene and 4-acetylaminofluorene in normal and initiated/selected hepatocytes: relation with the "resistant" phenotype.
    Nizard C; Martin M; Decloitre F
    Cell Biol Toxicol; 1993; 9(1):61-76. PubMed ID: 8518970
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Metabolic activation in isolated rat hepatocytes.
    Casciano DA
    SAAS Bull Biochem Biotechnol; 1990 Jan; 3():102-6. PubMed ID: 1366416
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Cadmium-2-acetylaminofluorene interaction in isolated rat hepatocytes.
    Moffatt P; Marion M; Denizeau F
    Cell Biol Toxicol; 1992; 8(4):277-90. PubMed ID: 1493587
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Gas chromatography-mass spectrometry analysis of tert.-butyldimethylsilyl derivatives of 2-acetylaminofluorene and metabolites in isolated rat hepatocytes.
    Diez Ibañez MA; Chessebeuf-Padieu M; Nordmann P; Padieu P
    Cell Biol Toxicol; 1987 Sep; 3(3):327-40. PubMed ID: 3507261
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Induction of cMrp/cMoat gene expression by cisplatin, 2-acetylaminofluorene, or cycloheximide in rat hepatocytes.
    Kauffmann HM; Keppler D; Kartenbeck J; Schrenk D
    Hepatology; 1997 Oct; 26(4):980-5. PubMed ID: 9328323
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Impaired nuclear accumulation and shortened phosphorylation of ERK after growth factor stimulation in cultured hepatocytes from rats exposed to 2-acetylaminofluorene.
    Skarpen E; Lindeman B; Thoresen GH; Guren TK; Oksvold MP; Christoffersen T; Huitfeldt HS
    Mol Carcinog; 2000 Jun; 28(2):84-96. PubMed ID: 10900465
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Bone marrow-derived hepatic oval cells differentiate into hepatocytes in 2-acetylaminofluorene/partial hepatectomy-induced liver regeneration.
    Oh SH; Witek RP; Bae SH; Zheng D; Jung Y; Piscaglia AC; Petersen BE
    Gastroenterology; 2007 Mar; 132(3):1077-87. PubMed ID: 17383429
    [TBL] [Abstract][Full Text] [Related]  

  • 75. DNA adduct formation and removal in hepatic chromatin fractions from rats chronically fed 2-acetylaminofluorene.
    Poirier MC; Fullerton NF; Patterson ED; Beland FA
    Carcinogenesis; 1990 Aug; 11(8):1343-7. PubMed ID: 2387020
    [TBL] [Abstract][Full Text] [Related]  

  • 76. The carcinogen 2-acetylaminofluorene inhibits activation and nuclear accumulation of cyclin-dependent kinase 2 in growth-induced rat liver.
    Lindeman B; Skarpen E; Oksvold MP; Huitfeldt HS
    Mol Carcinog; 2000 Mar; 27(3):190-9. PubMed ID: 10708481
    [TBL] [Abstract][Full Text] [Related]  

  • 77. DNA adduct formation, removal and persistence in rat liver during one month of feeding 2-acetylaminofluorene.
    Poirier MC; Hunt JM; True BA; Laishes BA; Young JF; Beland FA
    Carcinogenesis; 1984 Dec; 5(12):1591-6. PubMed ID: 6499111
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Generation of reactive dysmorphogenic intermediates by rat embryos in culture: effects of cytochrome P-450 inducers.
    Juchau MR; Bark DH; Shewey LM; Greenaway JC
    Toxicol Appl Pharmacol; 1985 Dec; 81(3 Pt 1):533-44. PubMed ID: 4082200
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Immunohistochemical localization of DNA adducts in rat liver tissue and phenotypically altered foci during oral administration of 2-acetylaminofluorene.
    Huitfeldt HS; Spangler EF; Hunt JM; Poirier MC
    Carcinogenesis; 1986 Jan; 7(1):123-9. PubMed ID: 3510747
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Relationship between oxidative metabolism of 2-acetylaminofluorene, debrisoquine, bufuralol, and aldrin in human liver microsomes.
    McManus ME; Boobis AR; Minchin RF; Schwartz DM; Murray S; Davies DS; Thorgeirsson SS
    Cancer Res; 1984 Dec; 44(12 Pt 1):5692-7. PubMed ID: 6498831
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.